Comparison of synovial fluid cartilage marker concentrations and chondral damage assessed arthroscopically in acute knee injury  by Bello, Alfonso E. et al.
Osteoarthritis and Cartilage (1997) 5, 419-426 
1997 Osteoarthritis Research Society 1063-4584/97/060419+ 08 $12.00/0 
OSTEOARTHRITIS 
and 
CARTILAGE 
Comparison of synovial fluid cartilage marker concentrations and 
chondral damage assessed arthroscopically in acute knee injury 
BY ALFONSO E. BELLO*, WILLIAM E. GARRETT JR.]', HAO WANG~:, JOHN LOHNESj', ELIZABETH DELONGw 
BRUCE CATERSON[I AND VIRGINIA B. KRAUS* 
*Departments of Medicine (Rheumatology, Allergy, and Clinical Immunology), tSurgery (Orthopaedic 
Surgery), w and Family Medicine (Biometry) at Duke University Medical Center, Durham, 
North Carolina 27710; r of Orthopaedic Surgery, University of North Carolina at Chapel 
Hill, Chapel Hill, North Carolina 27599, U.S.A.; IlSchool of Molecular Medicine, University of North 
Wales, Cardif/, Wales, U.K. 
Summary 
Objective: To examine the correlation between synovial fluid cartilage markers and degree of cartilage damage 
determined by arthroscopic evaluation in subjects with acute knee injury. 
Design: Chondral damage was quantified using a validated arthroscopic scoring system in 20 subjects with effusive 
acute knee injuries of less then 4 months duration and no history or radiographic evidence of joint pathology. Levels 
of synovial fluid 3B3(-) neoepitope, 3B3(+) chondroitinase g nerated epitope of proteoglycan, keratan sulfate (KS) and 
hyaluronic acid (HA) were measured by competitive enzyme-linked immunosorbent assays using monoclonal ntibodies 
3B3 and 5D4. Total sulfated glycosaminoglycan (GAG) was measured by 1,9-dimethylmethylene blue colorimetric 
dye-binding assay. 
Results: We found a dramatic decrease in levels of 3B3(-) (rs =-0.62, P= 0.004), and GAG (r~ =-0.49, P= 0.03) with 
increasing chondral damage score; but no correlation of damage score with 3B3(+), KS or HA levels. 
Conclusion: These data reveal a change in cartilage metabolism within the first 4 months of symptomatic knee injury 
evinced by a significant inverse correlation of 3B3(-) and GAG levels to chondral lesion severity. These results uggest 
that serial measurement of hese synovial fluid markers in the setting of acute knee injury could predict chondral lesion 
severity and aid in the decision to intervene surgically. 
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Introduction 
IN the U.S., osteoarthrit is (OA) is second only to 
ischemic heart disease as a cause of work disability 
in men over 50 years of age, accounting for more 
hospitalizations than rheumatoid arthrit is each 
year [1]. Despite this public health impact, current 
available OA therapies are generally pall iative 
and delivered late in the disease course, when 
destruction of art icular carti lage is advanced and 
detectable radiographical ly [2]. Based on studies of 
OA in animal models, it is suspected that the peak 
of disease activity occurs well before the condit ion 
can be diagnosed radiographical ly [3]. Thus, the 
identif ication of sensitive markers for the earl ier 
stages of osteoarthrit is (preradiographic OA), 
and an understanding of the correlation of 
markers to disease course and severity, would 
represent a major advance, facil itating early 
diagnosis, treatment monitoring and the rat ional 
development of effective therapy. 
Received 13March 1997; accepted 9 July 1997. 
Epitopes of carti lage extracel lular matrix mol- 
ecules found in body fluids are potential indicators 
of the state of carti lage metabolism and arthrit is. 
A subpopulation of patients with acute injury 
of the knee provides a model system for evaluating 
whether the distribution and concentrat ion 
of these markers correlates with the extent 
of art icular carti lage damage at an early stage, 
prior to radiographic evidence of joint disease [3]. 
3B3(-) is a neo-epitope on chondroitin-6-sulfate 
(CS) chains detected by monoclonal ant ibody 
(MAb) 3B3 in the absence of chondroit inase ABC 
pretreatment. 3B3(-) expression is low or absent in 
normal carti lage specimens and demonstrable in 
arthrit is where carti lage degeneration, remodeling 
and repair are greatest [4]. 3B3(-) has been 
detected in synovial fluid (SF) from OA and 
chronical ly injured joints (>4 weeks duration) 
but not from acutely injured joints (<4 
weeks duration) [5]. 3B3(+), is a chondroit inase- 
generated CS epitope identified by MAb 3B3 
representat ive of unsaturated CS in proteoglycan 
[4]. Chondroit inase-generated CS has been shown 
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to be lower in SF from OA and rheumatoid 
arthritic joints compared with normals [6]. The 
MAb 5D4 reacts against several repeats of a highly 
sulfated heptasaccharide in keratan sulfate (KS), 
a glycosaminoglycan (GAG) found in cartilage 
proteoglycan [7]. Lower SF concentrations of 
KS are found in acutely injured human knees 
compared with the contralateral uninjured knees 
of the same patients [8], in arthritic human joints 
compared with normal controls [6], and in OA 
compared with chronically injured joints [5]. 
Hyaluronic acid (HA) can originate from 
both synovium and cartilage but is generally 
considered a marker of synovial inflammation [9]. 
The concentration f HA in SF has been shown to be 
lower in acutely injured effusive joints compared 
with acutely injured non-effusive or normal joints 
[10]. To date SF levels of HA have not been 
compared with arthroscopic evidence of chondral 
damage. 
The purpose of this study was to examine the 
diagnostic value of SF marker levels in effusive 
acutely injured knee joints by comparing marker 
levels to chondral lesion severity as determined by 
a validated arthroscopic scoring system. SF 
marker levels from joints with chondral damage 
were compared with levels from joints without 
chondral damage in subjects with acute knee 
injury duration of less than 4 months. Advantages 
of the acute knee injury model system include 
knowledge of the event inciting cartilage damage, 
precise diagnosis of the injury through 
arthroscopy, and a comparatively rapid disease 
process [3]. 
Pat ients  and Methods  
DESIGN 
We performed a prospective study of acute knee 
injury, defined as an interval from injury of less 
than 4 months, presenting for orthopaedic evalu- 
ation and deemed to require arthroscopy. The 
design was a blinded comparison of chondral 
damage (quantitated arthroscopically using a 
validated scoring system) and SF concentrations 
of the cartilage xtracellular matrix constituents, 
3B3(-) neo-epitope, 3B3(+) chondroitinase-gener- 
ated CS epitope of proteoglycan, KS, and HA using 
enzyme-linked immunosorbent assays (ELISA) and 
total GAG. 
PAT IENTS 
Patients meeting the following criteria were 
recruited consecutively from the Sports Medicine 
Clinic at Duke University Medical Center: 
(1) scheduled to undergo non-research arthro- 
scopy, (2) acute knee injury within 4 months of 
arthroscopy, (3) patient age between 18 and 60 
years, (4) no evidence of joint pathology on plain 
radiographs, (5) no history of intra-articular or 
oral corticosteroid exposure, (6) no other rheuma- 
tologic disorder. The majority of patients were 
referred from either the local health maintenance 
organization (the Duke Health Network), the Duke 
University Student Health Service, or fee for 
service. The study thus included a broad range of 
knee injuries and age groups. Knee radiographs 
included standing anteroposterior and lateral 
views reviewed by a single observer (A.E.B.) who 
was blinded to biochemical nd arthroscopic data. 
The choice of patients with duration of injury less 
than 4 months was based upon evidence from 
previous tudies howing alteration in the concen- 
trations of SF cartilage matrix components 
by knee injury during this time interval [3]. A 
clinical description of the 20 patients with acute 
knee injury is summarized in Table I. The age 
range of patients was from 19-57 years, with a 
median of 34 years, and all patients had normal 
knee radiographs, although two had histories 
of knee trauma without effusion more than 1 year 
before study entry. The majority were male 
(18/20), and sustained an acute injury to the knee 
a mean of 9.3 weeks before arthroscopy. All 
subjects showed evidence of internal derange- 
ment at arthroscopy: nine with both an anterior 
cruciate ligament (ACL) and a meniscal tear, seven 
with an ACL tear only, and four with a meniscal 
tear only. Abnormal synovium was apparent in 13 
participants. The study was approved by the 
institutional review board at Duke University 
Medical Center. 
SF 
SF was aspirated from the suprapatellar pouch 
before injection of intra-articular anesthesia for 
arthroscopy. Fluid was immediately aliquoted and 
stored at -70~ 
CRITERION STANDARD 
Arthroscopic examination of the knee was done 
using the French Society of Arthroscopy (SFA) 
system for assessing articular cartilage which 
has been validated [11-13]. This instrument 
scores all three compartments of the knee (medial, 
lateral, and patellofemoral), yielding a continuous 
variable between 0 and 100 for each compartment. 
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The following formula was used to determine the 
score: 
SFA score=size (%) of grade I lesion x 0.14 + size 
(%) of grade II lesions x 0.34 + size (%) of grade III 
lesions x 0.65 + size (%) of grade IV lesions x 1.00. 
Lesion size, size (%), is expressed as a percent 
based on a visual analog scale as scored by the 
arthroscopist. For each compartment, the size (%) 
for a particular grade corresponds to the mean 
value for the two articular surfaces of the 
compartment [12]. Grade was based on a classifi- 
cation of chondropathy in which 0 indicates 
normal cartilage, I indicates welling and soften- 
ing, II indicates superficial fibrillation, III indi- 
cates deep fibrillation, and IV indicates exposure 
of subchondral bone [13]. Other internal derange- 
ments were recorded, such as ACL tear, meniscal 
injury or the presence of abnormal synovium, 
defined as hyperemia, thickening or villous 
proliferation. All evaluations were performed by a 
single examiner (W.E.G.). 
MEASUREMENT OFSULFATED TOTAL GAG 
SF GAG content was quantitated using the 
1,9-dimethylmethylene blue dye (Aldrich 34,108-8) 
assay performed according to the method of 
Farndale [14] with modifications [8 15]. Shark CS 
standards (Sigma C4384) in the range of 0-50 pg/ml 
were prepared in water, and the shift in the 
absorbance after the addition of the dye was 
monitored immediately at 540 nm on an Anthos 
Reader 2001. 
3B3 ELISA 
A quantitative ELISA was developed for 
3B3(-) neo-epitope recognized by the MAb 3B3. 
This assay was carried out in 96-well microtiter 
plates (Immulon 4, Scientific Products), coated 
overnight at 4~ with a bovine aggrecan core 
standard protein (chondroitinase ABC-digested 
A1D1 fraction of bovine nasal cartilage, BNC) 
in 0.02 M sodium carbonate, pH 9.6, 100 pl/well. 
Known concentrations of bovine core standard 
or serially diluted SF samples were prepared in 
Tris 1B (an incubation buffer containing 0.01 M 
Tris-HC1 pH 7.4, 0.15 M NaC1, 0.1% Nonidet P-40, 
0.1% bovine serum albumin and 0.003 M sodium 
azide). Sixty microliters of standard or sample 
were mixed with 60 pl 3B3 MAb (1:30 000 final 
dilution) and incubated overnight at 4~ Repli- 
cate assays of all samples were performed. For 
3B3(-) determination, SF was not digested with 
chondroitinase ABC; for 3B3(+), SF was digested 
with chondroitinase before assay. Antigen coated 
plates were washed four times with Tris IB then 
blocked with 100 ~l of a 1% bovine serum albumin 
solution in Tris IB for 90min at 37~ The 
remainder of the assay conformed with previously 
published methods [15] with the exception that 
Tris IB was used as the incubation buffer 
throughout. The absorbance at 405 nm was read on 
an Anthos Reader 2001. The amount of epitope in 
the samples was calculated from the absorbance 
readings falling within the linear portion of the 
standard curve and expressed in micrograms per 
milliliter. 
5D4 EL ISA  
Determination of KS levels in SF using the 5D4 
MAb was carried out using the 3B3 ELISA 
protocol except, 5D4 antibody was used at a final 
dilution of 1 : 250 000. These assays were normalized 
to an international standard competitor, 'KS-2', 
kindly provided by Dr Eugene Thonar. A 1.0 ng 
protein sample of our aggrecan standard was found 
to be equivalent to 0.12 ng of purified KS-2. All KS 
results are reported as microgram per milliliter of 
KS-2 equivalent. 
MEASUREMENT OF HA 
HA was measured by competitive ELISA using a 
modification of a procedure developed by Goldberg 
[9]. This assay relies upon HA binding exogenous 
aggrecan, capture of unbound aggrecan on an HA 
coated plate and detection with the 5D4 MAb. HA 
(Sigma H1876, grade III) derived from human 
umbilical cord was stored at -20~ as a I mg/ml 
stock in water and diluted to 100 gg/ml concen- 
tration in standard coating buffer just before 
plate coating. Immulon 4 plates were coated with 
100pl of diluted HA per well and incubated 
overnight at 4~ All subsequent dilutions and 
plate washes were performed in Tris IB. A special 
grade HA (Seikagaku 400724-1), also derived from 
human umbilical cord, was used as the standard 
competitor in these assays and maintained as a 
1 mg/ml stock in water. Known concentrations of
special grade HA competitor or SF samples were 
prepared in Tris IB. Sixty microliters of standard 
or sample were incubated with 60 ~1 BNC (ABC) 
core (final 0.25 pg/ml) overnight at 4~ Plates were 
blocked 90min at 37~ with 1% bovine serum 
albumin, then washed four times, followed by 
addition of 100 pl of the special grade HA/standard 
core protein mixture or 100 pl of the SF dilution/ 
standard core protein mixture, and incubated 1h 
at 4~ Plates were washed, incubated with 
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antibody 5D4, followed by secondary antibody and 
substrate as for the 5D4 ELISA. 
STAT IST ICAL  ANALYS IS  
Demographic data were tabulated as means for 
continuous variables and as counts and percents 
for dichotomous variables. The Spearman corre- 
lation analysis was performed to compare chondral 
damage scores with individual cartilage marker 
levels. The Wilcoxon-Mann-Whitney two-sample 
test was used to compare the chondral damage 
scores for the dichotomous variables (presence or 
absence of ACL tear, meniscal injury or abnormal 
synovium), and to compare cartilage marker 
concentrations when chondral damage scores were 
dichotomized into patients with chondral damage 
(SFA > 0) and those without damage (SFA=0). 
Multivariable linear and logistic regression analy- 
ses were performed to evaluate for a correlation 
between cartilage marker concentrations and 
chondral damage scores. P-values less than or 
equal to 0.05 (two-sided) were considered signifi- 
cant. We used the SAS statistical package to 
perform all analyses [16]. 
obtained from trauma-affected joints with no 
chondral damage (SFA=0) were compared with 
those that had chondral damage (SFA > 0), a 
significant decrease in the lesioned group for 
3B3(-) epitope (P=0.008), and GAG (P=0.05) 
was observed (Table II). In addition, when the 
statistical analysis was performed excluding the 
two individuals with previous remote knee trauma, 
results were unchanged. 
COMPARISON OF ARTHROSCOPIC  DATA TO CHONDRAL 
DAMAGE SCORE 
To determine whether a particular internal 
derangement correlated with chondral damage, we 
performed a multivariate logistic regression analy- 
sis upon SFA score and lesion type. The finding of 
any meniscal pathology (N=13) was associated 
with an increased chondral damage score (P = 0.02) 
(Table III). ACL tear (N= 16), either alone (N= 7) 
or in combination with meniscal injury (N=9), 
showed no independent correlation with chondral 
damage. The coexistence of abnormal synovium 
(N=13) showed no significant correlation with 
chondral damage. 
Resu l ts  
CORRELAT ION BETWEEN MARKERS AND CHONDRAL 
DAMAGE 
Eight participants had a chondral damage 
score of 0 indicating normal articular cartilage by 
direct visualization. The remaining 12 participants 
with chondral damage had a mean chondral 
damage score of 9.3 (range 0.7-30.6). Spearman 
correlation analysis showed a highly significant 
decrease in SF levels of 3B3(-) epitope (r~ =-0.62, 
P=0.004) with increased chondral damage score 
[Fig. l(b)]. A significant negative association was 
also found between GAG (rs =-0.49, P= 0.03) and 
increasing chondral damage score [Fig. l(d)]. 
No significant correlation was found between 
chondral damage score and levels of 3B3(+), 
KS and HA [Fig. l(a), (c) and (e)], SF volume, 
patient age, or time interval from injury. Nor 
was there a significant correlation of the con- 
centration of any marker to time interval from 
injury, patient age, or SF volume. There was no 
significant effect of the presence of abnormal 
synovium on marker levels. Statistics were also 
performed using parametric techniques yielding 
the same results. 
The group with SFA scores of 0 can be viewed as 
an internal control group. When the concert- 
trations of 3B3(-), 3B3(+), KS, HA, and GAG 
PREDICT ION OF CHONDRAL DAMAGE 
Meniscat pathology correlated irectly, while 
3B3(-) epitope levels and GAG levels correlated 
inversely, with chondral damage scores (P _< 0.05). 
In the multivariable rank-transformed linear 
regression model, controlling for meniscal pathol- 
ogy, the relationship between 3B3(-) epitope levels 
and chondral damage score was still significant 
(P=0.01), with an odds ratio of 0.4, and 95% 
confidence interval of 0.002--0.636. However for 
GAG, results were no longer significant after 
controlling for meniscal pathology (P = 0.38). 
Discuss ion  
Previous studies have examined proteoglycan 
fragments in body fluids following injury, compar- 
ing levels to different methods of quantifying 
articular damage [17-20]. Though arthroscopy has 
been considered the 'gold standard' for assessing 
articular cartilage [21, 22], only recently has there 
been a validated system of quantification [13]. 
This system, developed by the SFA, yields a score 
that takes into account depth, size, and location of 
articular cartilage lesions in each compartment of 
the knee, and has demonstrated xcellent intraob- 
server reliability. The scoring system as used in 
this study, with a single observer carrying out all 
the measurements, was sensitive nough to show a 
424 Bell| et al . :  Synovial fluid markers and acute knee injury 
250 
200 
150 
i00 
50 
(a) 
O 
| 
@ 
| 
@ @ 
. . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . . . . . .  
_~ | |  | 
$ e 
I _ _1~ I _ I _ _  I _ I I _ _  
0 5 10 15 20 25 30 35 
SFA 
2.00 
1.50 
1.00 
I 
0.50 
0.00 
(b) 
@ 
@ 
S 
I I [ I I I F 
0 5 10 15 20 25 30 
SFA 
35 
350 
300 
250 
200 
~" 150 
100 
50 
(c) 
@ 
| 
@ @ 
O | 
| o - - - -  . . . . .  | . . . .  
| 
_ _ ~  I _~ I I __  b L _ _  
0 5 10 15 20 25 30 35 
SFA 
500 
400 
300 
200 
100 
(d) 
o 
o 
o 
$ 
- -  Q 
o 
o 
0 
e - - -~O 
o 
I _ I I I _1  _1 
5 10 15 20 25 30 35 
SFA 
12 000 
10 000 
8000 
6000 
4000 
2000 
0 
(e) 
@ 
O 
$ 
@ 
Q e 
9 9 | 
o 
- -  I |  9 
O 
_ _ ~ o  _ ~  / _ _  I J . _  I _  I _ _  
0 5 10 15 20 25 30 35 
SFA 
FIG. 1. Synovial fluid marker concentrations with chondral damage. Concentrations (~g/ml) of SF markers are plotted 
versus individual SFA scores for (a) keratan sulfate (KS), (b) 3B3(-), (c) 3B3(+), (d) total glycosaminoglycan (GAG), 
and (e) hyaluronic acid (HA). A statistically significant decrease in 3B3(-) (r~ =-0.62, P = 0.004) and GAG (r~ =-0.49, 
P= 0.03) occurs with chondral damage. 
clear difference in 3B3 and GAG marker levels 
with chondral damage. 
Intuitively, an increase in SF carti lage markers 
might be expected with increased chondral 
damage. However, the converse was observed by us 
and others [6, 8, 23-25]. We found that SF 3B3(-) 
epitope levels and GAG levels were inversely 
correlated to extent of articular carti lage damage. 
Inverse correlations of SF markers and disease 
severity include, (1) proteoglycan and radio~ 
graphic severity in rheumatoid arthritis (RA) [23], 
(2) KS and radiographic severity of OA [24], (3) KS 
and acute knee injury compared with contralateral 
uninjured joint [8], and (4) KS and GAG levels in 
OA and RA compared with normal controls [6]. 
Similar findings have also been seen with 
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Table II 
SFA chondral damage score and corresponding mean values ( + SE) for synovial fluid 
markers for the 20 patients 
SFA 0 SFA > 0 P-value 
3B3(-) 1.14 • 0.16 0.65 + 0.08 0.008 
3B3(+) 117.95 +_ 39.38 73.23 • 14.05 0.56 
Keratan  sulfate 72.85 _+ 24.71 73.78 • ii,31 0.42 
Total sulfated g lycosaminoglycan 291.3 _+ 43.6 179.2 _+ 22.7 0.05 
Hyaluronic acid 4503.4 +_ 1004.2 5460.5 +_2276.0 0.46 
proteoglycan fragments, where SF levels were 
influenced by the mass of cartilage matrix 
remaining in the joint [26]. Our data demonstrate 
a change occurring in cartilage metabolism within 
the first 4 months of symptomatic knee injury. 
Marker levels appear to reflect the volume of 
remaining normal cartilage or the metabolic state 
of the cartilage such that lower turnover occurs 
with increasingly severe lesions. Mean SF 3B3(-) 
epitope concentrations were approximately two- 
fold higher in injured joints without chondral 
damage (SFA=0) compared with joints with 
chondral damage (SFA > 0). Although SF 3B3(-) 
epitope levels in normal human joints have not 
been reported previously to our knowledge, we are 
able to detect very small quantities of 3B3(-) 
epitope by ELISA in undiluted SF from normal 
mature canine joints (unpublished data). Levels of 
3B3(-) from normal canine joints are 13-fold lower 
than the lowest 3B3(-) levels in effusive acute knee 
injury detected in the cohort with chondral 
damage. Thus, 3B3(-) levels in acute effusive knee 
injury appear to be elevated above normal and 
decline in conjunction with increasing chondral 
damage. Early decline of 3B3(-) following acute 
knee injury, and correlation of 3B3(-) levels with 
chondral pathology in our patients, suggest he 
potential of 3B3(-) to serve as a marker of cartilage 
lesion severity in this population. 
In our study, meniscal pathology was indepen- 
dently associated with articular cartilage damage 
independent of markers. We did not find an 
association between SF 3B3(+), KS or HA marker 
levels and extent of articular cartilage damage. 
This may be due, in part, to a small sample size. 
Although serum HA has demonstrated utility as a 
predictor of disease progression in humans with 
OA of the knee [27], no correlation between SF HA 
and cartilage damage has been discerned in equine 
studies [28]. Synovium was defined as abnormal if 
hyperemia, thickening, or villous proliferation was 
seen at arthroscopy. We did not find a significant 
effect of these abnormalities on SF marker levels, 
although SF marker clearance is enhanced by 
calcium pyrophosphate dihydrate-induced synovi- 
tis [29]. It is possible that the inflammatory 
reaction in acute knee injury is too low initially to 
increase the clearance of proteoglycan fragments. 
The use of body fluid markers for predicting 
articular cartilage damage is an optimistic goal 
with an ever increasing potential for realization as 
our understanding of cartilage biochemistry in 
health and disease is refined. A diagnostic 
algorithm may be possible in the future utilizing 
both biochemical markers and sensitive imaging 
techniques to identify patients for early interven- 
tion, prior to radiographically demonstrable carti- 
lage damage. We were interested to find that the 
inverse correlation between lesion severity and SF 
markers was independent of time interval from 
injury within the 4 month interval from injury 
evaluated in this study. This results lends credence 
to the future possibility of predicting chondral 
damage by serial measurements of SF marker 
levels in a select population with acute knee 
injury. Continued diagnostic studies with larger 
numbers of subjects are needed before such a 
possibility can come to fruition and clinical use. 
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